鉴定BRAF互动组的特征识别了黑色素瘤中的BRAF V600ETP53相互作用
bioRxiv : the preprint server for biology
|July 16, 2025
概括
黑色素瘤中的BRAF V600E突变可能会使瘤抑制剂TP53失活,这解释了为什么TP53变异在这种侵袭性癌症中很罕见. 这一发现揭示了黑色素瘤发展的新机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 黑色素瘤是一种具有攻击性,转移性癌症,发病率不断上升.
- 大多数黑色素瘤都会激活MAPK信号通路,通常是通过BRAF V600E突变.
- 除了MAPK激活之外,BRAF V600E的具体作用尚不清楚.
研究的目的:
- 研究BRAF V600E在黑色素瘤中的新功能.
- 为了区分野生型BRAF与BRAF V600E的互动体.
- 确定BRAF V600E.E.的新交互合作伙伴.
主要方法:
- 使用TurboID近距离标记来绘制蛋白质相互作用的地图.
- 将野生型BRAF的互动组与BRAF V600E突变的互动组进行比较.
- 分析了蛋白质相互作用伙伴,专注于TP53.
主要成果:
- 确定了针对BRAF V600E.特定的新型蛋白质相互作用体.
- 发现BRAF V600E与瘤抑制剂TP53.3相互作用.
- 观察到TP53的变化在黑色素瘤中并不常见,与其他癌症不同.
结论:
- 通过直接相互作用,BRAF V600E可能会使TP53失活.
- 这种相互作用为BRAF V600E驱动的黑色素瘤中TP53损失的罕见性提供了潜在的机制.
- 表明BRAF V600E在黑色素瘤发病过程中的新瘤作用.
更多相关视频
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.2K
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
3.0K
相关概念视频
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
